In this rare disease use case, MMIT demonstrates how NorstellaLinQ leverages structured and unstructured real-world data (RWD) to uncover new patients, quantify potential populations, and guide commercial, payer, and physician education strategies.
Quantify Rare Disease Populations
Identify and validate the size of a rare disease patient group using integrated RWD.
Commercial and Payer Strategy
Build effective market access, education, and physician targeting strategies.
HEOR Storytelling
Develop robust evidence to communicate value and outcomes to payers.
Reducing Risk: 5 Steps for a Fearless Launch